152 related articles for article (PubMed ID: 16827153)
1. Effect of rosiglitazone on N-nitroso-N-methylurea-induced mammary tumors in rat.
Núñez M; Martín G; Cocca C; Mohamad N; Gutiérrez A; Cricco G; Medina V; Rivera E; Croci M; Crescenti E; Bergoc R
Anticancer Res; 2006; 26(3A):2113-22. PubMed ID: 16827153
[TBL] [Abstract][Full Text] [Related]
2. Effect of glibenclamide on N-nitroso-N-methylurea-induced mammary tumors in diabetic and nondiabetic rats.
Cocca C; Martín G; Núñez M; Gutiérrez A; Cricco G; Mohamad N; Medina V; Croci M; Crescenti E; Rivera E; Bergoc R
Oncol Res; 2005; 15(6):301-11. PubMed ID: 16408695
[TBL] [Abstract][Full Text] [Related]
3. Effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.
Osborne MP; Ruperto JF; Crowe JP; Rosen PP; Telang NT
Cancer Res; 1992 Mar; 52(6):1477-80. PubMed ID: 1540955
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors.
Matsumoto H; Koibuchi Y; Horiguchi J; Iino Y; Morishita Y
Oncol Rep; 2002; 9(1):145-51. PubMed ID: 11748473
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
[TBL] [Abstract][Full Text] [Related]
6. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
[TBL] [Abstract][Full Text] [Related]
7. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
[TBL] [Abstract][Full Text] [Related]
8. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
9. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Gottardis MM; Jordan VC
Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
[TBL] [Abstract][Full Text] [Related]
10. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
Morimoto T; Yamamoto H; Komaki K; Konishi N; Tanaka T; Yamakawa T; Mori T; Sasa M; Monden Y
Tokushima J Exp Med; 1990 Dec; 37(3-4):59-68. PubMed ID: 2128782
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
McDougal A; Wormke M; Calvin J; Safe S
Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
[TBL] [Abstract][Full Text] [Related]
12. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
13. Prolonged decrease of adipocyte size after rosiglitazone treatment in high- and low-fat-fed rats.
Johnson JA; Trasino SE; Ferrante AW; Vasselli JR
Obesity (Silver Spring); 2007 Nov; 15(11):2653-63. PubMed ID: 18070756
[TBL] [Abstract][Full Text] [Related]
14. Effects of sequential and combined immuno-endocrine therapies using OK-432 (Picibanil) and tamoxifen on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
Iino Y; Yoshida M; Tago T; Owada S; Sugamata N; Horiuchi R
Jpn J Clin Oncol; 1991 Feb; 21(1):35-8. PubMed ID: 1906118
[TBL] [Abstract][Full Text] [Related]
15. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of prolactin on expression of Ia antigen by tumor cells.
Bernard DJ; Maurizis JC; Chassagne J; Chollet P; Plagne R
J Natl Cancer Inst; 1986 Jun; 76(6):1237-42. PubMed ID: 3012179
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor profiles: changes in mouse and rat mammary tumors by treatment with selective estrogen receptor modifiers.
Actis AM; Cocca CM; Gutierrez A; Croci M; Rivera ES; Bergoc RM
Med Princ Pract; 2004; 13(4):220-6. PubMed ID: 15181328
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination.
Gotoh T; Yamada K; Ito A; Yin H; Kataoka T; Dohi K
Jpn J Cancer Res; 1998 May; 89(5):487-95. PubMed ID: 9685851
[TBL] [Abstract][Full Text] [Related]
18. Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors.
Martin G; Melito G; Rivera E; Levin E; Davio C; Cricco G; Andrade N; Caro R; Bergoc R
Cancer Lett; 1996 Feb; 100(1-2):227-34. PubMed ID: 8620446
[TBL] [Abstract][Full Text] [Related]
19. Polyamines as mediators of the effect of prolactin and growth hormone on the growth of N-nitroso-N-methylurea-induced rat mammary tumor cultured in vitro in soft agar.
Manni A; Wright C
J Natl Cancer Inst; 1985 Apr; 74(4):941-4. PubMed ID: 3857388
[TBL] [Abstract][Full Text] [Related]
20. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.
Anzano MA; Byers SW; Smith JM; Peer CW; Mullen LT; Brown CC; Roberts AB; Sporn MB
Cancer Res; 1994 Sep; 54(17):4614-7. PubMed ID: 8062253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
